Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(91)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Aug 16, 2024 8:06pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
Notable Azzark isn't me and I'm not him/her. By the way thanks for correcting my "pocket" gaffe.
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 1:06pm
RE:RE:RE:RE:RE:RE:RE:RE:RE: Pelareorep + Paclitaxel = ADC/HER2 failed breast cancer
August 12, 2024 - Oncology, rare diseases, and immunology will likely continue to be hot targets for investors, and snapping up drugs from smaller startups has advantages over in-house development
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 11:20am
RE:RE:RE:RE:TIGIT class of checkpoint inhibitors fails with Keytruda
At Genentech, Mellman oversaw the discovery and development of Tecentriq — the checkpoint inhibitor that is central to Roche’s oncology portfolio – Lunsumio, and the company’s anti-TIGIT program. ONCY
...more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 11:10am
RE:RE:RE:TIGIT class of checkpoint inhibitors fails with Keytruda
August 16, 2024 - TIGIT fallout sees Roche/Genentech VP Immunology Ira Mellman on his way out. TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy Journal for
...more
(1395)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Aug 16, 2024 9:55am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
Nope, never had dual accounts. Cowardly people post under 2 different names for reasons I can only imagine.
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 9:46am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
Should read : ... increasingly circling ONCY
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 9:42am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
But I think I'm still right about your dual identity even though as Azzal34 you've been stand up.
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 9:40am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
Ok. All's good.
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 9:39am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
So yes. The prospect of an Accelerated Approval will have BP frenzied with excitement and increasingly circiling ONCY.
(1395)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Aug 16, 2024 9:36am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
Haha Noteable, that was me correcting his statement about the FDA. Just stick with the posts on pharma, you're good at that. The other stuff not so much.
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 9:34am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
venture aka Azzak34 ?? The corrective post under Azzak34 sure looks like that.
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 16, 2024 9:30am
RE:RE:RE:How does Accelerated Approval work
And I posted on the Accelerated Approval process for that long .... So by ONCY beginning the process of enrolling between 180-200 patients in a monotherapy pelareorep + paclitaxel clinical
...more
(1395)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Aug 16, 2024 7:22am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
Correction...... FDA is in BPs pocket.
(91)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Aug 15, 2024 11:15pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024
Notable, an AA has been predicted here for a number of yeard now, so the million dollar question is can they get this approval before any radical financial procedures? If an AA is in the cards
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed